GM1 ganglioside
GM1神经节苷脂
Report date: 2024/08/02 20:01:06
NME
Base Information
Drug NameGM1 ganglioside
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesLz Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesSun Yat-Sen University
Active IndicationsN/A
Inactive Indications +[5]
Other Information
ATC CodeN/A
Related LinksWikipedia